Clinical Trial

The PACT (Patient Activation Through Conversations) Study

Study acronym: PACT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 13, 2024 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The PACT Study is a cluster randomised trial of a health coach-led patient activation program in type 2 diabetes. The goal of this clinical trial is to evaluate the effectiveness of a health coaching intervention (PACT program) led by Care Coaches (trained lay persons), in adult participants with sub-optimally controlled Diabetes Mellitus, as compared to participants undergoing routine care for diabetes (Usual Care). The primary outcome of interest is change in Glycated Haemoglobin (HbA1c) levels over 3 months, 6 months and 12 months. Secondary outcomes include changes in blood pressure, low-density lipoprotein-cholesterol (LDL-C) levels, body mass index (BMI), self-reported diabetes self-care behaviours, self-efficacy, health-related quality of life, and diabetes-related distress, over 3, 6 and 12 months. Participants in the Intervention arm will undergo the PACT Program, which is a 3-month long health coaching program led by a care coach. Participants review their motivators, health parameters, self-care behaviours, and set goals for improving their diabetes using a PACT report. Subsequently, they will receive fortnightly motivational and problem solving support via telephone or WhatsApp messaging over a 3-month duration, and will return to routine care after 3 months. Participants in the Usual Care arm will have routine care of their diabetes treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-30.
Trial Details
NCT Number NCT06444074
Lead Sponsor National Healthcare Group Polyclinics
Collaborators: National Healthcare Group, Singapore
Conditions Diabetes Mellitus, Diabetes Mellitus, Type 2
Enrollment 432 participants
Start Date 2024-04-22
Primary Completion 2025-03-31 (estimated)
Study Completion 2028-04-22 (estimated)
Updated on ClinicalTrials.gov 2024-06-13